Membrane transport of drugs in different regions of the intestinal tract of the rat

Journal of Pharmaceutical Sciences
A L UngellH Lennernäs

Abstract

Regional permeability coefficients of 19 drugs with different physicochemical properties were determined using excised segments from three regions of rat intestine: jejunum, ileum, and colon. The results are discussed in relation to the characteristics of the drug, i.e., MW (range 113-1071 Da), pKa, log D (octanol/water at pH 7.4) (range -3.1 to +2.4), and the regional change in the properties of the epithelial membrane. There was a significant decrease in permeability to hydrophilic drugs and a significant increase in permeability for hydrophobic drugs aborally to the small intestine (P < 0.0001). A good correlation could be obtained between MW and permeability coefficients of hydrophilic drugs. The correlation established between the apparent permeability coefficients and the partition coefficients of the drugs was sigmoidal in shape in all three regions and a log D between 0 and 2.5 predicts high permeability values. These permeability data are unique since they result from a diversity of chemical structures with different physicochemical characteristics and a variety of transport mechanisms and they are not influenced by interlaboratory differences. The large regional permeability database in the present study shows the uti...Continue Reading

References

Dec 1, 1992·Alimentary Pharmacology & Therapeutics·S A RileyL A Turnberg
Sep 1, 1989·Pharmaceutical Research·G M Grass, W T Morehead
Jan 1, 1986·The Journal of Clinical Investigation·A B ThomsonK Walker
Dec 3, 1973·JAMA : the Journal of the American Medical Association·D Hollander, J Harlan
Apr 1, 1974·Journal of Pharmaceutical Sciences·G L FlynnT J Roseman
Dec 1, 1967·Gut·J P Wilson
Oct 1, 1995·Gastroenterology·R M SchwartzM D Levitt
Mar 1, 1995·Pharmaceutical Research·H LennernäsR Hällgren
Dec 1, 1994·Pharmaceutical Research·P E LunerG W Radebaugh
Jul 1, 1994·The Journal of Pharmacy and Pharmacology·H TakanagaA Tsuji
Aug 1, 1994·The American Journal of Physiology·M B LandeM L Zeidel
Apr 1, 1994·Digestive Diseases and Sciences·P KrugliakT Y Ma
Mar 1, 1993·Digestive Diseases and Sciences·A Strocchi, M D Levitt
Jul 1, 1996·Pharmaceutical Research·A Tsuji, I Tamai
Sep 1, 1996·Pharmaceutical Research·U FagerholmH Lennernäs
Jan 1, 1996·Journal of Pharmaceutical Sciences·K PalmP Artursson
Nov 1, 1996·Clinical Pharmacology and Therapeutics·A LindahlH Lennernäs

❮ Previous
Next ❯

Citations

Mar 5, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sofia BerggrenHans Lennernäs
Sep 29, 2001·Advanced Drug Delivery Reviews·B AgoramM B Bolger
Sep 29, 2001·Advanced Drug Delivery Reviews·D WagnerP Langguth
Sep 23, 2000·International Journal of Pharmaceutics·J Van GelderP Augustijns
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A NakayamaB J Aungst
Mar 7, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T OsterbergP Lundahl
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·P V BalimaneR A Morrison
Mar 8, 2011·Molecular Pharmaceutics·Oded OvadiaAmnon Hoffman
Aug 28, 1998·The Journal of Pharmacy and Pharmacology·A LindahlH Lennernäs
Jan 1, 2005·Environmental Health Perspectives·Tom Van de WieleSteven Siciliano
Aug 23, 2002·Clinical Pharmacokinetics·Patric StenbergPer Artursson
Feb 22, 2012·Clinical Pharmacokinetics·Yan-Ling He
Jun 23, 2011·Indian Journal of Pharmaceutical Sciences·N NagareMeena Chintamaneni
Dec 3, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tanira A S AguirreDavid J Brayden
Feb 18, 2016·The American Journal of Gastroenterology·Ricard Farré
Mar 1, 2009·Expert Review of Clinical Pharmacology·Nikoletta Fotaki
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kiyohiko Sugano
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Christel A S Bergström
Jun 6, 2008·Expert Opinion on Drug Delivery·Leonid Kagan, Amnon Hoffman
May 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Saeed AlqahtaniAmal Kaddoumi
Jan 26, 2010·Expert Opinion on Drug Delivery·Yunjin Jung, Young Mi Kim
Oct 23, 2003·Drug Development and Industrial Pharmacy·Daniel WagnerPeter Langguth
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·V Hayden ThomasAyman El-Kattan
Jun 16, 2012·Drug Metabolism Reviews·Peter BallardPeter J H Webborn
Oct 27, 2005·International Journal of Radiation Biology·I DublineauP Gourmelon
Apr 22, 2015·Journal of Pharmaceutical Sciences·Isabel Lozoya-AgulloMarival Bermejo
Oct 13, 2015·Journal of Pharmaceutical Sciences·Hisanao KishimotoKatsuhisa Inoue
Sep 8, 2010·Journal of Pharmaceutical Sciences·James M Butler, Jennifer B Dressman
Oct 15, 2009·Journal of Pharmaceutical Sciences·Johanna LinnankoskiMarjo Yliperttula
Aug 21, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C HeinenP Langguth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.